2022 Severe Asthma Digital Marketing Trends Report Featuring Sanofi, Regeneron, Genentech, Novartis, GSK, AstraZeneca, Amgen, and Teva

2022 Severe Asthma Digital Marketing Trends Report Featuring Sanofi, Regeneron, Genentech, Novartis, GSK, AstraZeneca, Amgen, and Teva

DublinAnd the November 21, 2022 /PRNewswire/ – File Digital Marketing Trends in Severe Asthma The report has been added to ResearchAndMarkets.com Present.

Analysis and Markets emblem

Dupixent.com Sanofi/Regeneron has the very best visitors throughout branded extreme asthmatics websites within the US from July 2021 to me June 2022with about 7,800,000 hits, adopted by Novartis’ Xolair.com and GSK’s Nucala.com.

The very best share of visitors to those websites originated from direct sources, adopted by natural searches. Amgen/AstraZeneca affiliate Tezspire.com had probably the most direct visitors (83%), whereas the remaining manufacturers, corresponding to Dupixent, Cinqair, Nucala, and Xolair, had ranges between 52-66%.

For patient-branded websites, Sanofi/Regeneron spent practically probably the most on DDA for Dupixent.com. $4.2 millionadopted by GSK’s Nucala.com approx $900,000. Dupixent.com was supported by the very best paying key phrases with roughly 10,650 key phrases, adopted by Tezspire.com with roughly 5,800 key phrases.

As for branded HCP websites within the US, Sanofi/Regeneron’s Dupixenthcp.com had probably the most visitors with practically 775,000 hits, adopted by AstraZeneca’s Fasenrahcp.com and GSK’s Nucalahcp.com. The very best share of visits to those websites originated from direct sources, adopted by natural and referral sources.

Teva’s Cinqairhcp.com had the very best visitors from direct searches (81%). Sanofi/Regeneron Spends The Most On DDA For Virtually Dupixenthcp.com $51,400adopted by Amgen/AstraZeneca Tezspirehcp.com approx $17,100.

between July 2021 And the June 2022, the highest 20 bronchial asthma social media posts by interplay from drugs had been from Sanofi’s Fb accounts, Genentech’s Instagram, Regeneron’s Instagram, Fasenra’s Fb, and GSK’s Instagram. AstraZeneca’s Vik Bronchial asthma app is the one drug-detected extreme bronchial asthma app within the US, with an estimated 30,700 downloads in 2021.

Most EUCAN branded web sites are affected person oriented and generate only some excessive profile hits July 2021 And the June 2022. Sanofi/Regeneron Dupixentmyway.co.uk and Dupixent.co.uk had the very best visitors with round 20,200 and three,400 hits respectively.

between July 2021 And the June 2022Eight of the highest 20 social media posts about bronchial asthma by interplay in EUCAN Medicines had been from the AstraZeneca Espana Instagram account. Bronchial asthma-specific cellular apps of medicines are usually not detected in EUCAN.

Area

  • This report assesses key digital advertising metrics for pharmaceutical belongings in extreme bronchial asthma, together with branded web sites for sufferers and healthcare professionals (HCPs), cellular apps, and social media accounts.

  • Metrics embody web site visitors quantity, engagement, supply, digital show promoting (DDA), paid search engine marketing (search engine optimisation), cellular app downloads, and social media engagement.

  • Nations embody america, 4EU (ItaliaAnd the FranceAnd the GermanyAnd the Spain) and the UK and Canada (EUCAN).

Causes to purchase

  • Understanding of the aggressive panorama of digital advertising in extreme bronchial asthma, with publicity to main Affected person and HCP branded belongings throughout totally different areas.

  • Be taught concerning the techniques pharmaceutical firms use to drive visitors to their asthma-branded acute belongings for sufferers and healthcare suppliers, corresponding to paid DDA and search engine optimisation.

  • Perceive the sources of web site visitors that generate probably the most visitors to those belongings, corresponding to paid search engine optimisation, social media, or natural searches.

  • Evaluate the most effective branded belongings for sufferers by how they meet and assist totally different affected person wants.

  • Discover out which drug-for-severe bronchial asthma social media accounts are probably the most lively and have probably the most engagement.

  • Try the main acute bronchial asthma cellular app choices of medicines throughout totally different areas.

Predominant matters coated:

  • Government abstract

  • Affected person branded web sites in america

  • US HCP-branded web sites

  • Digital show promoting and search engine marketing

  • Cellular apps and social media within the US

  • EUCAN branded web sites

  • EUCAN cellular apps and social media

  • trailing

talked about firms

  • Sanofi

  • Regeneron

  • Genentech

  • Novartis

  • GSK

  • AstraZeneca

  • Amgen

  • teva

For extra data on this report go to https://www.researchandmarkets.com/r/dzcu6v

Media contact:
Analysis and markets
Laura Woodenmentor supervisor
[email protected]

For EST workplace hours, name +1-917-300-0470
For US/Canada, name toll-free at +1-800-526-8630
For GMT workplace hours, name +353-1-416-8900

US fax: 646-607-1907
Fax (exterior the US): +353-1-481-1716

Emblem: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

Cision

Cision

View authentic content material:https://www.prnewswire.com/news-releases/severe-asthma-digital-marketing-trends-report-2022-featuring-sanofi-regeneron-genentech-novartis-gsk-astrazeneca-amgen–teva-301683667.html

SOURCE Analysis and Markets

#Extreme #Bronchial asthma #Digital #Advertising and marketing #Traits #Report #That includes #Sanofi #Regeneron #Genentech #Novartis #GSK #AstraZeneca #Amgen #Teva

Leave a Comment

Your email address will not be published. Required fields are marked *